Pathophysiologically, CAR T‐cell recognition of tumor cells induces a burst of IFN‐γ and other effector cytokines that activate monocytes/macrophages, which then amplify the inflammatory cascade through secretion of IL‐6, IL‐1, IL‐10, and TNF. Here, IL6 is linked to neoplasm.